申请人:Takeda Pharmaceutical Company Limited
公开号:EP3342772A1
公开(公告)日:2018-07-04
The present invention provides a heterocyclic compound having a HDAC inhibitory action, and useful for the treatment of inflammatory disease and the like, and a medicament comprising the compound.
The present invention relates to a compound represented by the formula (I):
wherein each symbol is as defined in the specification, or a salt thereof.
本发明提供了一种具有 HDAC 抑制作用、可用于治疗炎症等疾病的杂环化合物,以及一种包含该化合物的药物。
本发明涉及一种由式(I)代表的化合物:
其中各符号如说明书中所定义,或其盐。